Alexithymia in Parkinson's disease: a point of view on current evidence

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Taylor GJ. Recent developments in alexithymia theory and research. Can. J. Psychiatry 45, 134–142 (2000).
  Medline CASGoogle Scholar
• 2 Lumley MA, Neely LC, Burger AJ. The assessment of alexithymia in medical settings: implications for understanding and treating health problems. J. Pers. Assess. 89(3), 230–246 (2007).
  MedlineGoogle Scholar
• 3 Bonnaire C, Bungener C, Varescon I. Alexithymia and gambling: a risk factor for all gamblers? J. Gambl. Stud. 29, 1–14 (2013).
  MedlineGoogle Scholar
• 4 Shishido H, Gaher RM, Simons JS. I don't know how I feel, therefore I act: alexithymia, urgency and alcohol problems. Addict. Behav. 38, 2014–2017 (2013).
  MedlineGoogle Scholar
• 5 Ricciardi L, Demartini B, Fotopoulou A, Edwards MJ. Alexithymia in neurological disease: a review. J. Neuropsychiatry Clin. Neurosci. 27(3), 179–187 (2015).
  MedlineGoogle Scholar
• 6 Wood RL, Doughty C. Alexithymia and avoidance coping following traumatic brain injury. J. Head Trauma Rehabil. 28(2), 98–105 (2013).
  MedlineGoogle Scholar
• 7 Costa A, Caltagirone C. Individual differences in approach-avoidance aptitude: some clues from research on Parkinson's disease. Front. Syst. Neurosci. 24(9), 43 (2015).
  Google Scholar
• 8 Costa A, Peppe A, Carlesimo GA, Pasqualetti P, Caltagirone C. Alexithymia in Parkinson's disease is related to severity of depressive symptoms. Eur. J. Neurol. 13(8), 836–841 (2006).
  Medline CASGoogle Scholar
• 9 Costa A, Peppe A, Carlesimo GA, Salamone G, Caltagirone C. Neuropsychological correlates of alexithymia in Parkinson's disease. J. Int. Neuropsychol. Soc. 13(6), 980–992 (2007).
  MedlineGoogle Scholar
• 10 Costa A, Peppe A, Carlesimo GA, Salamone G, Caltagirone C. Prevalence and characteristics of alexithymia in Parkinson's disease. Psychosomatics 51(1), 22–28 (2010). • Allows the comparison between alexithymia rates observed in Parkinson's disease (PD) and in others medical conditions.
  MedlineGoogle Scholar
• 11 Assogna F, Palmer K, Pontieri FE et al. Alexithymia is a non-motor symptom of Parkinson disease. Am. J. Geriatr. Psychiatry 20(2), 133–141 (2012).
  MedlineGoogle Scholar
• 12 Goerlich-Dobre KS, Probst C, Winter L. Alexithymia-an independent risk factor for impulsive-compulsive disorders in Parkinson's disease. Mov. Disord. 29(2), 214–220 (2014). • This study documents, in PD patients, a significant association between some facets of alexithymia and impulsive-compulsive behavior.
  MedlineGoogle Scholar
• 13 Castelli L, Tonello D, Rizzi L, Zibetti M, Lanotte M, Lopiano L. Alexithymia in patients with Parkinson's disease treated with DBS of the subthalamic nucleus: a case–control study. Front. Psychol. 13(5), 1168 (2014).
  Google Scholar
• 14 Poletti M, Frosini D, Pagni C et al. Alexithymia is associated with depression in de novo Parkinson's disease. Psychother. Psychosom. 80(4), 251–225 (2011).
  MedlineGoogle Scholar
• 15 Poletti M, Frosini D, Pagni C et al. Parkinson's Alexithymia is associated with impulsivity in newly-diagnosed, drug-naïve patients with disease: an affective risk factor for the development of impulse-control disorders? J. Neuropsychiatry Clin. Neurosci. 24(4), E36–E37 (2012).
  MedlineGoogle Scholar
• 16 Enrici I, Adenzato M, Ardito RB et al. Emotion processing in Parkinson's disease: a three-level study on recognition, representation and regulation. PLoS ONE 10(6), e0131470 (2015). • Documents a nonsignificant association between dopamine medication and alexithymia.
  MedlineGoogle Scholar
• 17 Bogdanova Y, Cronin-Golomb A. Alexithymia and apathy in Parkinson's disease: neurocognitive correlates. Behav. Neurol. 27(4), 535–545 (2013). • Findings from this study shows in PD patients, that alexithymia may be associated with executive and visual-spatial performance.
  MedlineGoogle Scholar
• 18 Parker JD, Bagby RM, Taylor GJ. Alexithymia and depression: distinct or overlapping constructs? Compr. Psychiatry 32(5), 387–394 (1991).
  Medline CASGoogle Scholar
• 19 Wood RL, Williams C. Neuropsychological correlates of organic alexithymia. J. Int. Neuropsychol. Soc. 13(3), 471–479 (2007).
  MedlineGoogle Scholar
• 20 Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AFA. Systematic review of prevalence studies of depression in Parkinson's disease. Mov. Disord. 23, 183–189 (2008).
  MedlineGoogle Scholar
• 21 Bagby RM, Parker JDA, Taylor GJ. The Twenty-Item Toronto Alexithymia Scale-I. Item selection and cross- validation of the factor structure. J. Psychosom. Res. 38, 23–32 (1994).
  Medline CASGoogle Scholar
• 22 Bagby RM, Parker JDA, Taylor GJ. The Twenty-Item Toronto Alexithymia Scale-II. Convergent, discriminant, and concurrent validity. J. Psychosom. Res. 38, 33–40 (1994).
  Medline CASGoogle Scholar
• 23 Robbins TW, Cools R. Cognitive deficits in Parkinson's disease: a cognitive neuroscience perspective. Mov. Disord. 29, 597–607 (2014).
  MedlineGoogle Scholar
• 24 Dickson DW, Braak H, Duda JE et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol. 8, 1150–1157 (2009).
  Medline CASGoogle Scholar
• 25 Agid Y, Ruberg M, Hirsch E et al. Are dopaminergic neurons selectively vulnerable to Parkinson's disease? Adv. Neurol. 60, 148–164 (1993).
  Medline CASGoogle Scholar
• 26 Costa A, Peppe A, Mazzù I, Longarzo M, Caltagirone C, Carlesimo GA. Dopamine treatment and cognitive functioning in individuals with Parkinson's disease: the “cognitive flexibility” hypothesis seems to work. Behav. Neurol. 2014, 260896 (2014).
  MedlineGoogle Scholar
• 27 Yeterian EH, Pandya DN. Prefrontostriatal connections in relation to cortical architectonic organization in rhesus monkeys. J. Comp. Neurology 312, 43–67 (1991).
  Medline CASGoogle Scholar
• 28 Gündel H, López-Sala A, Ceballos-Baumann AO et al. Alexithymia correlates with the size of the right anterior cingulate. Psychosom. Med. 66(1), 132–140 (2004).
  MedlineGoogle Scholar
• 29 Sturm VE, Levenson RW. Alexithymia in neurodegenerative disease. Neurocase 17(3), 242–250 (2011).
  MedlineGoogle Scholar
• 30 Berthoz S, Artiges E, Van De Moortele PF et al. Effect of impaired recognition and expression of emotions on frontocingulate cortices: an fMRI study of men with alexithymia. Am. J. Psychiatry 159(6), 961–967 (2002).
  MedlineGoogle Scholar
• 31 Prigatano GP, Schacter DL. Awareness of Deficit After Brain Injury: Clinical and Theoretical Issues. Oxford University Press, New York, NY, USA (1991).
  Google Scholar
• 32 Kudlicka A, Clare L, Hindle JV. Awareness of executive deficits in people with Parkinson's disease. J. Int. Neuropsychol. Soc. 19(5), 559–570 (2013).
  MedlineGoogle Scholar
• 33 Amanzio M, Monteverdi S, Giordano A, Soliveri P, Filippi P, Geminiani G. Impaired awareness of movement disorders in Parkinson's disease. Brain Cogn. 72(3), 337–346 (2010).
  MedlineGoogle Scholar
• 34 Bird G, Silani G, Brindley R, White S, Frith U, Singer T. Empathic brain responses in insula are modulated by levels of alexithymia but not autism. Brain 133, 1515–1525 (2010).
  MedlineGoogle Scholar
• 35 Grynberg D, Luminet O, Corneille O, Grezes J, Berthoz S. Alexithymia in the interpersonal domain: a general deficit of empathy? Pers. Individ. Dif. 49, 845–850 (2010).
  Google Scholar
• 36 Guttman H, Laporte L. Alexithymia, empathy, and psychological symptoms in a family context. Compr. Psychiatry 43, 448–455 (2002).
  MedlineGoogle Scholar
• 37 Bodden ME, Mollenhauer B, Trenkwalder C et al. Affective and cognitive Theory of Mind in patients with parkinson's disease. Parkinsonism Relat. Disord. 16(7), 466–470 (2010).
  MedlineGoogle Scholar
• 38 Costa A, Peppe A, Martini M et al. Parkinsonian patients with deficits in the dysexecutive spectrum are impaired on theory of mind tasks. Behav. Neurol. 27(4), 523–533 (2013).
  MedlineGoogle Scholar